Biosynth

Biosynth — Acquisitions

Every M&A deal made by Biosynth, sorted by date.

Total deals 8 Total value $30.0M View company profile →
8
Total deals
$30.0M
Total value
$30.0M
Avg deal
$30.0M
Largest
Acquisition activity by year
Deals announced per year
22 23
# Acquired Date Type Status Price
1
VIO Chemicals
VIO Chemicals is a chemical company that offers customized chemical solutions to…
2023-12-19 Acquisition Complete Deal →
2
Celares
Celares is a pharmaceutical biotechnology industry.
2023-07-11 Acquisition Complete Deal →
3
Cambridge Research Biochemicals
Cambridge Research Biochemicals is a leading independent producer of custom-made…
2023-05-09 Acquisition Complete Deal →
4
Fitzgerald Industries International
Fitzgerald Industries International is manufactures supplies antibodies, protein…
2023-04-20 Acquisition $30.0M Deal →
5
EUCODIS Bioscience
EUCODIS Bioscience delivered high-performance enzyme solutions for applications …
2022-08-02 Acquisition Complete Deal →
6
Pepscan
Pepscan employs protein mimicry techniques for the R&D of therapeutic drugs and …
2022-06-30 Acquisition Complete Deal →
7
Aalto Bio Reagents
Aalto Bio Reagents is providing raw materials to medical industry.
2022-05-25 Acquisition Complete Deal →
8
vivitide
Vivitide specializes in antibody packages and custom peptide synthesis services …
2022-03-17 Acquisition Complete Deal →